Advertisement
Screener

NovoCure Limited (NVCR) Cash

NovoCure Limited Cash

NovoCure Limited (NVCR) had Cash of $27.77 million as of 2021-09-30, per its 10-Q filed 2021-10-28.

Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments

us-gaap:Cash · last filed 2021-10-28

  • 2021-09-30: Cash $27.77M.
  • 2021-06-30: Cash $33.30M.
  • 2021-03-31: Cash $31.85M.
  • 2020-12-31: Cash $20.34M.
Period endCash
2021-09-30$27.77M
10-Q · filed 2021-10-28
2021-06-30$33.30M
10-Q · filed 2021-07-29
2021-03-31$31.85M
10-Q · filed 2021-04-29
2020-12-31$20.34M
10-Q · filed 2021-10-28
2020-09-30$25.59M
10-Q · filed 2020-10-29
2020-06-30$17.59M
10-Q/A · filed 2020-10-02
2020-03-31$8.19M
10-Q/A · filed 2020-10-02
2019-12-31$18.38M
10-Q · filed 2020-10-29
2019-09-30$5.85M
10-Q · filed 2019-10-31
2019-06-30$8.90M
10-Q · filed 2019-07-25
2019-03-31$9.10M
10-Q · filed 2019-05-02
2018-12-31$9.20M
10-Q · filed 2019-10-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77